Peptides · Peptide comparison
Buserelin vs Human Chorionic Gonadotropin (HCG)
A synthetic GnRH agonist that suppresses hormones to help treat prostate cancer, endometriosis, and infertility
A powerful hormone that mimics luteinizing hormone (LH) to stimulate your body's natural testosterone production while keeping your fertility intact—like having your cake and eating it too for men on hormone therapy.
- Hormone Support
- Hormone Support
At a glance
Quick comparison
Efficacy
Benefit ratings
Hormone Suppression
Cancer Management
Fertility Support
Fertility Preservation
Testicular Health
Hormone Balance
Technical data
Compound specifications
Buserelin
- Molecular formula
- C60H86N16O13
- Molecular weight
- 1239.4 g/mol
- Half-life
- 2-4 hours (subcutaneous), 30-60 minutes (intranasal); longer for depot formulation (28-40 days)
- Bioavailability
- ~1% (oral); ~10-15% (intranasal); ~95% (subcutaneous)
- CAS number
- 57773-65-6
Human Chorionic Gonadotropin (HCG)
- Molecular formula
- C1105H1770N318O336S26 (approximate)
- Molecular weight
- 36,700 g/mol (approximately)
- Half-life
- 24-36 hours
- Bioavailability
- High when injected subcutaneously or intramuscularly
- CAS number
- 9002-61-3
Protocols
Dosing compared
Buserelin
Subcutaneous
- 500 mcgEvery 8 hours (3 times daily) · First 7 daysThe product label starts prostate cancer treatment with 500 mcg under the skin every 8 hours for the first week [5].
- 200 mcgOnce daily · Ongoing maintenanceAfter the first week, the label switches to 200 mcg once daily under the skin for ongoing treatment [5].
Intranasal
- 400 mcg (2 sprays per nostril)3 times daily (1,200 mcg/day) · Ongoing maintenanceThe nasal spray option delivers 400 mcg three times a day as maintenance, an alternative to daily injections [5].
Implant
- 6.3 mgOnce every 2 months · Long-termA long-acting implant placed under the skin slowly releases buserelin over about 2 months, so no daily dosing is needed [5].
- 9.45 mgOnce every 3 months · Long-termA larger implant lasts about 3 months between placements [5].
Human Chorionic Gonadotropin (HCG)
Subcutaneous
- 500-1,500 IU2-3 times per week · Ongoing with TRTDocumented clinical practice for preserving testicular function/fertility in men on testosterone therapy; 1,500-2,000 IU 2-3x/week is used for hypogonadotropic hypogonadism [6]. The popular 500 IU 2-3x/week maintenance figure reflects real-world practice rather than the FDA label. In controlled dosing, 250 IU every other day held intratesticular testosterone within 7% of baseline and 500 IU raised it 26% above baseline during testosterone administration [7]; 500 IU every other day preserved semen parameters with no azoospermia in men on TRT [8].
Intramuscular
- 500-1,000 IU3 times weekly for 3 weeks, then 2 times weekly for 3 weeks · 6-week induction courseFDA-labeled regimen for male hypogonadotropic hypogonadism (Pregnyl) [7]. Intramuscular is the only labeled route.
- 4,000 IU then taper to 2,000 IU3 times weekly · 4,000 IU for 6-9 months, then 2,000 IU for 3 additional monthsHigher-dose FDA-labeled regimen for inducing spermatogenesis/testicular descent (Pregnyl) [7].
Applications
Best suited for
Buserelin
- Managing advanced prostate cancer
- Buserelin is particularly well-suited for individuals focused on managing advanced prostate cancer. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Treating endometriosis and reducing associated pain
- Buserelin is particularly well-suited for individuals focused on treating endometriosis and reducing associated pain. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
- Optimizing ovarian response during fertility treatments
- Buserelin is particularly well-suited for individuals focused on optimizing ovarian response during fertility treatments. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Human Chorionic Gonadotropin (HCG)
- Fertility Preservation During TRT
- If you're on testosterone therapy but want to keep your swimmers swimming, HCG is your best friend. It keeps your testes active and producing sperm even when external testosterone would normally shut that down. Research shows it can maintain or restore spermatogenesis in about 80% of men [3][4][8].
- Preventing Testicular Atrophy
- Nobody wants their boys to shrink. When you take external testosterone, your brain stops signaling your testes to work—and they get smaller from disuse. HCG mimics the signal (LH) that keeps them active, maintaining their size and function [6][14].
- Hypogonadotropic Hypogonadism
- If your pituitary gland isn't sending the right signals to your testes (low LH), HCG can step in and do the job. It's been used for decades to treat this condition, helping men achieve normal testosterone levels and fertility [3][6][13].
- Post-Cycle Therapy (PCT)
- After using anabolic steroids, your natural hormone production is suppressed. HCG can help jumpstart your testes back into action, speeding up the recovery of your natural testosterone production. It's often used as part of a comprehensive PCT protocol [9][15].
Safety profile
Side effects
Buserelin
No side effects recorded.
Human Chorionic Gonadotropin (HCG)
Common
- Injection site reactions
- Headache
- Water retention
Uncommon
- Gynecomastia
- Mood changes
- Acne
Serious
- Blood clots
Research status
Safety & evidence
Buserelin
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- Not FDA approved; no buserelin application in Drugs@FDA. Approved in Canada as SUPREFACT for advanced prostate cancer (injection and nasal solution) and endometriosis (nasal solution).
- Safety overview
- Buserelin is a GnRH agonist approved in Canada and Europe (not in the US), with safety data from Phase 3 trials and decades of clinical use, but carries well-documented risks from intentional testosterone/estrogen suppression. The initial testosterone flare (first 2-3 weeks) can worsen prostate cancer symptoms and cause tumor flare pain in 10-20% of patients. Long-term use causes bone density loss of 2-3% annually, with vertebral fractures in 10-20% of long-term users. Cardiovascular risks include increased MI and stroke in men over 65. Hot flashes affect 40-80%, erectile dysfunction is nearly universal, and liver enzyme elevations occur in 5%. Nasal spray formulation causes local irritation in 20-30% of users.
Contraindications
- Pregnancy or breastfeeding
- Hypersensitivity to GnRH agonists
- Certain bone diseases when long-term use is planned
Human Chorionic Gonadotropin (HCG)
- Evidence level
- Strong human trials (Phase 3 or FDA approved)
- FDA status
- FDA approved for other use
- Safety overview
- HCG has been used medically for over 80 years with a well-established safety profile. [10] When used appropriately for male hypogonadism or fertility preservation, side effects are generally mild and manageable. The most common issues relate to elevated estrogen from increased testosterone aromatization, which can be managed with aromatase inhibitors if needed. [6][18] Serious side effects are rare when HCG is used under medical supervision.
Contraindications
- Hormone-sensitive cancers (prostate, breast) [6][23]
- Precocious puberty in children [23]
- Known allergy to HCG or any component [6][23]
- Pregnancy (in therapeutic male contexts) [23]
- Untreated thyroid or adrenal disorders [6]
Decision guide
Which is right for you?
Buserelin
Choose Buserelin if…
- Managing advanced prostate cancer
- Treating endometriosis and reducing associated pain
- Optimizing ovarian response during fertility treatments
Human Chorionic Gonadotropin (HCG)
Choose Human Chorionic Gonadotropin (HCG) if…
- Fertility preservation during TRT
- Maintaining testicular size and function
- Natural testosterone stimulation
- Post-cycle therapy recovery